Plaintiffs in the pelvic mesh litigation have accused a Johnson & Johnson subsidiary of judge-shopping after the company asked a Philadelphia judge to recuse from an upcoming trial and also sought to have its appeal of a $13 million verdict assigned to a different appellate panel.
The new allegations come as the state appellate courts are beginning to wade into jurisdictional questions sparked by the U.S. Supreme Court’s Bristol-Myers Squibb v. Superior Court of California ruling, which could significantly shrink the pelvic litigation in Philadelphia and alter the city’s broader mass tort landscape.
